IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v590y2021i7845d10.1038_s41586-020-03180-w.html
   My bibliography  Save this article

Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury

Author

Listed:
  • Jordan W. Squair

    (Swiss Federal Institute of Technology (EPFL)
    Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
    Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Matthieu Gautier

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Lois Mahe

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Jan Elaine Soriano

    (University of Calgary
    University of Calgary
    University of Calgary
    University of Calgary)

  • Andreas Rowald

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Arnaud Bichat

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Newton Cho

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL
    University of Toronto)

  • Mark A. Anderson

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Nicholas D. James

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Jerome Gandar

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Anthony V. Incognito

    (University of Calgary
    University of Guelph)

  • Giuseppe Schiavone

    (Swiss Federal Institute of Technology (EPFL))

  • Zoe K. Sarafis

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Achilleas Laskaratos

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Kay Bartholdi

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Robin Demesmaeker

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Salif Komi

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Charlotte Moerman

    (Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Bita Vaseghi

    (University of Calgary
    University of Calgary
    University of Calgary)

  • Berkeley Scott

    (University of Calgary
    University of Calgary
    University of Calgary
    University of Calgary)

  • Ryan Rosentreter

    (University of Calgary
    University of Calgary
    University of Calgary
    University of Calgary)

  • Claudia Kathe

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Jimmy Ravier

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Laura McCracken

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Xiaoyang Kang

    (Swiss Federal Institute of Technology (EPFL))

  • Nicolas Vachicouras

    (Swiss Federal Institute of Technology (EPFL))

  • Florian Fallegger

    (Swiss Federal Institute of Technology (EPFL))

  • Ileana Jelescu

    (Swiss Federal Institute of Technology (EPFL))

  • YunLong Cheng

    (Motac Neuroscience Ltd)

  • Qin Li

    (Motac Neuroscience Ltd)

  • Rik Buschman

    (Medtronic)

  • Nicolas Buse

    (Medtronic)

  • Tim Denison

    (University of Oxford
    University of Oxford)

  • Sean Dukelow

    (University of Calgary
    University of Calgary
    University of Calgary
    University of Calgary)

  • Rebecca Charbonneau

    (University of Calgary
    University of Calgary)

  • Ian Rigby

    (University of Calgary, Calgary)

  • Steven K. Boyd

    (University of Calgary)

  • Philip J. Millar

    (University of Guelph)

  • Eduardo Martin Moraud

    (Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Marco Capogrosso

    (University of Fribourg)

  • Fabien B. Wagner

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL
    Université de Bordeaux, UMR)

  • Quentin Barraud

    (Swiss Federal Institute of Technology (EPFL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Erwan Bezard

    (Motac Neuroscience Ltd
    Université de Bordeaux, UMR
    Institut des Maladies Neurodégénératives, CNRS, UMR)

  • Stéphanie P. Lacour

    (Swiss Federal Institute of Technology (EPFL))

  • Jocelyne Bloch

    (Swiss Federal Institute of Technology (EPFL)
    Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
    Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Grégoire Courtine

    (Swiss Federal Institute of Technology (EPFL)
    Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
    Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
    Defitech Center for Interventional Neurotherapies (.NeuroRestore), CHUV/UNIL/EPFL)

  • Aaron A. Phillips

    (University of Calgary
    University of Calgary
    University of Calgary
    University of British Columbia)

Abstract

Spinal cord injury (SCI) induces haemodynamic instability that threatens survival1–3, impairs neurological recovery4,5, increases the risk of cardiovascular disease6,7, and reduces quality of life8,9. Haemodynamic instability in this context is due to the interruption of supraspinal efferent commands to sympathetic circuits located in the spinal cord10, which prevents the natural baroreflex from controlling these circuits to adjust peripheral vascular resistance. Epidural electrical stimulation (EES) of the spinal cord has been shown to compensate for interrupted supraspinal commands to motor circuits below the injury11, and restored walking after paralysis12. Here, we leveraged these concepts to develop EES protocols that restored haemodynamic stability after SCI. We established a preclinical model that enabled us to dissect the topology and dynamics of the sympathetic circuits, and to understand how EES can engage these circuits. We incorporated these spatial and temporal features into stimulation protocols to conceive a clinical-grade biomimetic haemodynamic regulator that operates in a closed loop. This ‘neuroprosthetic baroreflex’ controlled haemodynamics for extended periods of time in rodents, non-human primates and humans, after both acute and chronic SCI. We will now conduct clinical trials to turn the neuroprosthetic baroreflex into a commonly available therapy for people with SCI.

Suggested Citation

  • Jordan W. Squair & Matthieu Gautier & Lois Mahe & Jan Elaine Soriano & Andreas Rowald & Arnaud Bichat & Newton Cho & Mark A. Anderson & Nicholas D. James & Jerome Gandar & Anthony V. Incognito & Giuse, 2021. "Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury," Nature, Nature, vol. 590(7845), pages 308-314, February.
  • Handle: RePEc:nat:nature:v:590:y:2021:i:7845:d:10.1038_s41586-020-03180-w
    DOI: 10.1038/s41586-020-03180-w
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-020-03180-w
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/s41586-020-03180-w?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mary P. M. Fossey & Shane J. T. Balthazaar & Jordan W. Squair & Alexandra M. Williams & Malihe-Sadat Poormasjedi-Meibod & Tom E. Nightingale & Erin Erskine & Brian Hayes & Mehdi Ahmadian & Garett S. J, 2022. "Spinal cord injury impairs cardiac function due to impaired bulbospinal sympathetic control," Nature Communications, Nature, vol. 13(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:590:y:2021:i:7845:d:10.1038_s41586-020-03180-w. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.